Celltrion
068270.KS
$160.43
Share price
0.23%
Change (1 day)
-9.49%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Market capitalization of Celltrion (068270.KS)
Market cap: S$34.92 Billion
As of April 2025 Celltrion has a market cap of S$34.92 Billion. This makes Celltrion the world's 716th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Celltrion from 2007 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | S$34.92 B | -2.63% |
| 2024 | S$35.87 B | -18.88% |
| 2023 | S$44.21 B | 81.93% |
| 2022 | S$24.30 B | -22.46% |
| 2021 | S$31.34 B | -47.45% |
| 2020 | S$59.65 B | 122.22% |
| 2019 | S$26.84 B | -20.88% |
| 2018 | S$33.92 B | -1.45% |
| 2017 | S$34.42 B | 118.81% |
| 2016 | S$15.73 B | 37.62% |
| 2015 | S$11.43 B | 138.9% |
| 2014 | S$4.78 B | 5.88% |
| 2013 | S$4.51 B | -14.95% |
| 2012 | S$5.31 B | 12.37% |
| 2011 | S$4.72 B | 6.49% |
| 2010 | S$4.44 B | 139.85% |
| 2009 | S$1.85 B | 60.51% |
| 2008 | S$1.15 B | 4190.59% |
| 2007 | S$26.88 M |
End of Day market cap according to different sources
On Apr 5th, 2025 the market cap of Celltrion was reported to be:
S$34.92 Billion
S$34.92 Billion